Both wavelengths are ideal for performing vascular-related applications. The pulse-dye
laser is the "gold standard" for targeting vascular lesions such as portwine stains,
as well as smaller red vessels, scars and rosacea. Likewise, the Nd:YAG laser is
particularly effective at treating larger facial and leg veins.
MultiPlex's sequential dual-wavelength technology has been proven more efficacious
than single-wavelength technology because it allows client-specific treatment options;
including customizing the time delay between wavelength delivery.
The sub-purpuric, pulse-dye laser converts oxy-hemoglobin to methemoglobin and micro-clots-increasing
absorption of the Nd:YAG wavelength by 300 to 500 percent and thereby enabling reduced
Nd:YAG fluence for enhanced client safety. In addition, since greater penetration
depth is achieved, outcome results are optimised.
Since Cynergy's versatility ensures optimal treatment parameters, clients experience
fewer side effects. In fact, Cynergy virtually eliminates purpura; a bruising typically
associated with older pulse-dye lasers, as well as dramatically reduces the risk
By emitting dual wavelengths, Cynergy provides safe and effective results in less
time than single-wavelength systems. For clients, that means greater comfort and
Cynergy treats vascular lesions with unsurpassed efficacy and minimal side effects.
That's because the revolutionary MultiPlex technology enables the sequential emission
of two wavelengths from the same delivery system—a high-powered pulse-dye laser and
a 1064-nm long—pulse Nd:YAG laser.